Shanghai Genechem Co., Ltd. announced that it has received CNY 100,000,000 in a round of funding in January 2016. The transaction included participation from investors including HighLight Capital, China Renaissance Partners, Investment Arm, and returning investor Jiangsu Aoyang Health Industry Co.ltd. (SZSE:002172)